ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update
Go back to ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update| (NASDAQ: ASPI) | Delayed: 3.04 -0.2 (6.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.24 | 52 Week High | $ | |||
| Open | $3.30 | 52 Week Low | $ | |||
| Day High | $3.32 | P/E | N/A | |||
| Day Low | $3.04 | EPS | $ | |||
| Volume | 12,431,389 | |||||
| (NASDAQ: NDRA) | Delayed: 5.50 +0.08 (1.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.42 | 52 Week High | $ | |||
| Open | $5.37 | 52 Week Low | $ | |||
| Day High | $5.50 | P/E | N/A | |||
| Day Low | $5.10 | EPS | $ | |||
| Volume | 17,842 | |||||
